Researchers around the world are investigating ways to effectively train immune cells, including natural killer (NK) cells, to target specific types of tumors. NK cells represent a form of immunotherapy that is potentially a less toxic and more effective way to combat tumor cells than current standard cancer treatment protocols, which heavily rely on chemotherapy and radiation.

The Nova Southeastern University (NSU) Cell Therapy Institute led by accomplished cancer researcher Richard Jove, Ph.D., is actively collaborating with scientists from the world-renowned Karolinska Institutet (KI) in Sweden, home of the scientists who discovered NK cells, to develop a full-circle investigative process to expedite discoveries. They are initially focusing on pediatric sarcomas, which receive less research funding than more common forms of cancer.

The goal is to take these discoveries and ultimately transfer them to develop durable cures for various other forms of cancer. To learn more visit https://goo.gl/mczERv.